A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
Clinical trial NCT03637491 · TERMINATED
Trial details
- NCT number
- NCT03637491
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2020-12-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.